EcoDrugPlus

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSPPRG00000003195
Gene Symbol: AXL
3 Cross references
197 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPPRG00000024821
Gene Symbol: BRAF
4 Cross references
220 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSPPRG00000001150
Gene Symbol: BCL2
4 Cross references
227 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSPPRG00000022980
Gene Symbol: BCL2L1
4 Cross references
286 Possible Orthologues:

Bcl2 Like 2

Ensembl ID : ENSPPRG00000009965
Gene Symbol: BCL2L2
4 Cross references
64 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSPPRG00000002850
Gene Symbol: BCL2A1
4 Cross references
114 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSPPRG00000009899
Gene Symbol: BCR
3 Cross references
274 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSPPRG00000018074
Gene Symbol: BTK
3 Cross references
207 Possible Orthologues:

C-C Chemokine Receptor Type 5-Like

Ensembl ID : ENSPPRG00000015563
Gene Symbol: LOC109247710
3 Cross references
294 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSPPRG00000015584
Gene Symbol: CCR1
3 Cross references
299 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSPPRG00000000156
Gene Symbol: CCR2
2 Cross references
294 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSPPRG00000016036
Gene Symbol: CCR4
3 Cross references
254 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).